Literature DB >> 16257244

Autosomal dominant hereditary hemochromatosis associated with two novel Ferroportin 1 mutations in Spain.

V Bach1, A Remacha, A Altés, M J Barceló, M A Molina, M Baiget.   

Abstract

Hereditary hemochromatosis is a common disorder of iron metabolism most frequently associated with mutations in the HFE gene. Hereditary hemochromatosis may be caused by other genetic mutations including those in the SLC40A1 gene. This report describes the clinical and laboratory findings of two Spanish families with autosomal dominant iron overload associated with previously unrecognized Ferroportin 1 mutations (p.R88T and p.I180T). The phenotype of iron overload in the patients carrying these mutations could correspond to the group of clinical mutations that lose their iron export function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257244     DOI: 10.1016/j.bcmd.2005.09.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  7 in total

Review 1.  Non-HFE haemochromatosis.

Authors:  Daniel-F Wallace; V-Nathan Subramaniam
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

2.  Hereditary hemochromatosis in the post-HFE era.

Authors:  John K Olynyk; Debbie Trinder; Grant A Ramm; Robert S Britton; Bruce R Bacon
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

3.  Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.

Authors:  Roman Mayr; Andreas R Janecke; Melanie Schranz; William J H Griffiths; Wolfgang Vogel; Antonello Pietrangelo; Heinz Zoller
Journal:  J Hepatol       Date:  2010-07-17       Impact factor: 25.083

4.  The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data.

Authors:  Daniel F Wallace; V Nathan Subramaniam
Journal:  Genet Med       Date:  2015-12-03       Impact factor: 8.822

5.  Functional characterization of a novel SLC40A1 Arg88Ile mutation in a kindred with familial iron overload treated by phlebotomy.

Authors:  Jihad Womack; Abitha Sukumaran; Xiuqi Li; Larisa Lozovatsky; Patrick G Gallagher; Jerome E Seid; Karin E Finberg
Journal:  Blood Cells Mol Dis       Date:  2020-12-24       Impact factor: 3.039

Review 6.  Ferroportin disease: pathogenesis, diagnosis and treatment.

Authors:  Antonello Pietrangelo
Journal:  Haematologica       Date:  2017-11-03       Impact factor: 9.941

Review 7.  Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.

Authors:  L Tom Vlasveld; Roel Janssen; Edouard Bardou-Jacquet; Hanka Venselaar; Houda Hamdi-Roze; Hal Drakesmith; Dorine W Swinkels
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.